Martin Kolb, MD, PhD
McMaster University; Hamilton, ON
Session Description
This presentation will describe the recently published ATS clinical practice guideline “Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations”. The general process of guideline development will be covered and the specific questions of how to apply these to clinical practice will be discussed using case reports.
Learning Objectives
At the end of this presentation, attendees will be able to:
- Understand the methodology process of creating a clinical practice guideline
- Describe the evidence based recommendations for the treatment of SSc-ILD
- Apply these recommendations to clinical practice
CanMEDS Roles: Medical Expert, Professional, Scholar